Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Sep 19, 2014

29777_rns_2014-09-19_db4aa87f-8af5-4b43-8488-f2e88a3a900d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

SEC FORM 4 Page 1 of 2

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden hours per response: 0.5
1. Name and Address of Reporting Person Fussell Stephen R
--- --- ---
(Last) (First) (Middle) 100 ABBOTT PARK ROAD
(Street) ABBOTT PARK IL 60064-6400
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year)
Common shares without par value
Common shares without par value
Common shares without par value
Common shares without par value
Common shares without par value
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)
Option (right to buy) (3) $22.267 09/18/2014
Option (right to buy) (3) $23.2184 09/18/2014

Explanation of Responses:

  1. Balance in the Abbott Laboratories Stock Retirement Trust as of September 18, 2014.
  2. The reporting person disclaims beneficial ownership of all securities held by his spouse.
  3. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

John A. Berry, by power of

attorney for Stephen R.

Fussell

09/19/2014

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

http://www.sec.gov/Archives/edgar/data/1800/000117911014014360/xslF345X03/edgar.xml


SEC FORM 4 Page 2 of 2

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911014014360/xslF345X03/edgar.xml 9/19/2014